Oxcarbazepine Suspension
Product Images NDC 70377-117

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 70377-117). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle-label.jpg (Bottle Label)

This text provides information on the storage and usage of an oral suspension of Oxcarbazepine, with a dosage of 300 mg per 5 ml. It highlights the need to store the medication in its original container at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication guide enclosed or provided separately contains essential information for the patient. It also emphasizes the importance of shaking the suspension well before use. The product is manufactured by Carnegie Pharmaceuticals LLC for Biocon Pharma Inc. in Iselin, New Jersey, USA.*

FDA Label Image

Carton (Carton)

This is a description for Oxcarbazepine Oral Suspension, USP. Each 5 mL of the suspension contains 300 mg of oxcarbazepine. It is important to shake well before use. The medication guide should be provided to each patient. The suspension should be stored in its original container at a temperature between 20°C and 25°C. It is essential to keep this medication and all drugs out of the reach of children. Once opened, the suspension should be used within 7 weeks.*

FDA Label Image

Oxcarbazepine-fgure1 (Oxcarbazepine Fgure1)

FDA Label Image

Oxcarbazepine-fgure10 (Oxcarbazepine Fgure10)

FDA Label Image

Oxcarbazepine-fgure11 (Oxcarbazepine Fgure11)

FDA Label Image

Oxcarbazepine-fgure12 (Oxcarbazepine Fgure12)

FDA Label Image

Oxcarbazepine-fgure13 (Oxcarbazepine Fgure13)

FDA Label Image

Oxcarbazepine-fgure14 (Oxcarbazepine Fgure14)

FDA Label Image

Oxcarbazepine-fgure15 (Oxcarbazepine Fgure15)

FDA Label Image

Oxcarbazepine-fgure16 (Oxcarbazepine Fgure16)

FDA Label Image

Oxcarbazepine-fgure2 (Oxcarbazepine Fgure2)

FDA Label Image

Oxcarbazepine-fgure3 (Oxcarbazepine Fgure3)

FDA Label Image

Oxcarbazepine-fgure4 (Oxcarbazepine Fgure4)

FDA Label Image

Oxcarbazepine-fgure6 (Oxcarbazepine Fgure6)

FDA Label Image

Oxcarbazepine-fgure7 (Oxcarbazepine Fgure7)

FDA Label Image

Oxcarbazepine-fgure8 (Oxcarbazepine Fgure8)

FDA Label Image

Oxcarbazepine-fgure9 (Oxcarbazepine Fgure9)

FDA Label Image

Oxcarbazepine-structure (Oxcarbazepine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.